Novo Nordisk CEO Sees US Supply Curbs on Wegovy Into 2024
Limits on US supplies of starter doses of its hugely popular weight-loss drug will last into next year, says Novo Nordisk CEO.
Source: medscape.com
Stay updated with breaking news from Thursday Jorgensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Limits on US supplies of starter doses of its hugely popular weight-loss drug will last into next year, says Novo Nordisk CEO.
By Nikolaj Skydsgaard COPENHAGEN (Reuters) -Danish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular ...
Danish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular Wegovy weight-loss drug in the US to cope with consumer pressure.